RUSSIAN EXPERIENCE WITH USING MONOCLONAL ANTIBODIES TO B-LYMPHOCYTES (RITUXIMAB) IN SYSTEMIC VASCULITIDES ASSOCIATED WITH NEUTROPHIL CYTOPLASMIC ANTIBODIES (PRELIMINARY RESULTS OF THE RUSSIAN REGISTER NORMA)

In 2013, Russia registered officially the indications for the use of monoclonal antibodies to B-lymphocytes (rituximab, RTM) in systemic vasculitides associated with antineutrophil cytoplasmic antibodies (ANCA-SV). This communication presents the preliminary results of the Russian register of the RT...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Beketova, E. N. Aleksandrova, T. M. Novoselova, E. G. Sazhina, E. V. Nikolaeva, A. V. Smirnov, V. N. Sorotskaya, E. V. Zemerova, I. F. Nam, N. M. Nikitina, G. S. Arkhangelskaya, Z. R. Bagautdinova, I. N. Dashkov, S. Yu. Chernykh, O. V. Zhirnova, Yu. A. Lushpaeva, L. V. Masneva, I. P. Afanasieva, A. E. Arseniev, I. V. Kondratenko, I. B. Bashkova, S. I. Glukhova, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2014-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1918
Tags: Add Tag
No Tags, Be the first to tag this record!